Factor V Leiden / Prothrombin Gene Mutation Analysis
A Contract Award Notice
by WARRINGTON AND HALTON TEACHING HOSPITALS NHS FOUNDATION TRUST
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £4K
- Sector
- HEALTH
- Published
- 29 Jul 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Warrington
2 buyers
1 supplier
Description
Providing Factor V Leiden / Prothrombin Gene Mutation testing
Total Quantity or Scope
Provision of Factor V Leiden / Prothrombin Gene Mutation testing. The intention is to award the contract to an existing provider following Direct Award C The contract will run up until 31/03/2027 Total value of the contract is estimated £3,500
Award Detail
1 | Mersey & West Lancashire Teaching Hospitals NHS Trust (Liverpool)
|
Award Criteria
PRICE | _ |
CPV Codes
- 85111800 - Pathology services
Indicators
- Award on basis of price.
Legal Justification
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 12/08/2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR'.
Other Information
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 12/08/2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.' Decision-makers are Rachel Langdon and Neil Gaskell and there are no conflicts or potential conflicts of interest
Reference
- FTS 043872-2025